Browsing by Author "Sisteré-Oró, Marta"

Sort by: Order: Results:

  • Anti-SARS-COV-2 specific immunity in HIV immunological non-responders after mRNA-based COVID-19 vaccination
    Sisteré-Oró, Marta; Andrade, Naína; Wortmann, Diana D. J.; Du, Juan; Garcia Giralt, Natàlia; González Cao, María; Güerri Fernández, Roberto; Meyerhans, Andreas (Frontiers, 2022)
    Individuals infected with the human immunodeficiency virus type 1 (HIV-1) belong to the group of people most vulnerable to SARS-CoV-2 infections and the associated disease COVID-19. Here we describe SARS-CoV-2-specific ...
  • Assessment of human SARS CoV-2-Specific T-Cell responses elicited In Vitro by new computationally designed mRNA immunogens (COVARNA)
    Esteban, Ignasi; Pastor-Quiñones, Carmen; Usero, Lorena; Aurrecoechea, Elena; Franceschini, Lorenzo; Esprit, Arthur; Gelpí, Josep Lluís; Martínez-Jiménez, Francisco, 1988-; López Bigas, Núria; Breckpot, Karine; Thielemans, Kris; Leal, Lorna; Gómez, Carmen Elena; Sisteré-Oró, Marta; Meyerhans, Andreas; Esteban, Mariano; Alonso Fernández, María José; García, Felipe; Plana, Montserrat; COVARNA Consortium (MDPI, 2023)
    The COVID-19 pandemic has brought significant changes and advances in the field of vaccination, including the implementation and widespread use of encapsidated mRNA vaccines in general healthcare practice. Here, we present ...
  • Brief research report: Anti-SARS-CoV-2 immunity in long lasting responders to cancer immunotherapy through mRNA-based COVID-19 vaccination
    Sisteré-Oró, Marta; Wortmann, Diana D. J.; Andrade, Naína; Aguilar, Andrés; Mayo de las Casas, Clara de la Caridad; Garcia Casabal, Florencia; Torres, Susana; Bona Salinas, Eduardo; Raventos Soler, Laura; Arcas, Andrea; Esparre, Carlos; Garcia, Beatriz; Valarezo, Joselyn; Rosell, Rafael; Güerri Fernández, Roberto; Gonzalez-Cao, Maria; Meyerhans, Andreas (Frontiers, 2022)
    Cancer patients (CPs) have been identified as particularly vulnerable to SARS-CoV-2 infection, and therefore are a priority group for receiving COVID-19 vaccination. From the patients with advanced solid tumors, about 20% ...
  • Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate
    Moros, Alexandra; Prenafeta, Antoni; Barreiro, Antonio; Perozo, Eva; Fernández, Alex; Cañete, Manuel; González, Luis; Garriga, Carme; Pradenas, Edwards; Marfil, Silvia; Blanco Arbués, Julià; Cebollada Rica, Paula; Sisteré-Oró, Marta; Meyerhans, Andreas; Prat Cabañas, Teresa; March, Ricard; Ferrer, Laura (Elsevier, 2023)
    The continuing high global incidence of COVID-19 and the undervaccinated status of billions of persons strongly motivate the development of a new generation of efficacious vaccines. We have developed an adjuvanted vaccine ...
  • Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium
    Marcos Villar, Laura; Sisteré-Oró, Marta; Meyerhans, Andreas; Gómez, Carmen Elena (Nature Research, 2024)
    Vaccines based on mRNA technology have revolutionized the field. In fact, lipid nanoparticles (LNP) formulated with mRNA are the preferential vaccine platform used in the fight against SARS-CoV-2 infection, with wider ...
  • Pan-pox-specific T-cell responses in HIV-1-infected individuals after JYNNEOS vaccination
    Sisteré-Oró, Marta; Du, Juan; Wortmann, Diana D. J.; Filippi, Marina D.; Cañas-Ruano, Esperanza; Arrieta Aldea, Itziar; Marcos-Blanco, Agustín; Castells, Xavier; Grau Cerrato, Santiago; García-Giralt, Natalia; Perez-Zsolt, Daniel; Boreika, Rytis; Izquierdo-Useros, Nuria; Güerri Fernández, Roberto; Meyerhans, Andreas (Wiley, 2024)
    People living with human immunodeficiency virus (HIV) are the individuals most affected by the current Monkeypox virus outbreak that was first announced in May 2022. Here we report Pan-pox-specific T-cell responses in a ...
  • Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2
    Barreiro, Antonio; Sisteré-Oró, Marta; Cebollada Rica, Paula; Meyerhans, Andreas; Ferrer, Laura (Elsevier, 2023)
    Current COVID-19 vaccines have been associated with a decline in infection rates, prevention of severe disease, and a decrease in mortality rates. However, SARS-CoV-2 variants are continuously evolving, and development of ...
  • Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates
    Prenafeta, Antoni; Cebollada Rica, Paula; Sisteré-Oró, Marta; Meyerhans, Andreas; Ferrer, Laura (Elsevier, 2023)
    SARS-CoV-2 emerged in December 2019 and quickly spread worldwide, continuously striking with an unpredictable evolution. Despite the success in vaccine production and mass vaccination programs, the situation is not still ...

Search DSpace

Browse

My Account

In collaboration with Compliant to Partaking